ClinicalTrials.gg
RecruitingNCT05130203MouvMatUpdated Jun 13, 2024

Developing and Assessing an Innovative Exergaming Technology for Older Adults Living in Long-term Care Homes

An interventional study of MouvMat Exergaming and Standard Recreational Programming in Physical Inactivity, Cognitive Decline and Aging, sponsored by University of Toronto. Recruiting at 2 sites in Canada. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-13.

Sponsored by University of Toronto · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Oct 2022; still recruiting 4 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 73 studies in Sedentary Behavior with a site in Canada — 18 open to participants now, 19 under way, none of them phase 3. Sedentary Behavior · Canada.

Planned enrollment
30th of 69
60 · median 50
Started
2022
with 10 others
No phase
67 of 73
18 open now
Primary completion
2025-01
later than 2 of 18 live
Registered
38th of 73
by date
Lead sponsor
9 of 73
University of Toronto

Among the 73 studies in Sedentary Behavior with a site in Canada, this one is the 30th largest by planned enrollment of the 69 interventional ones that give a count, is one of 11 that started in 2022, is one of 67 with no phase, reaches primary completion later than 2 of the 18 other live ones, and was the 38th registered.

Sedentary Behavior

1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.

Browse Sedentary Behavior studies →

Open to participants now

18 of the 73 studies in Sedentary Behavior with a site in Canada are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.

This study: 55 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 73 studies in Sedentary Behavior with a site in Canada, or all of them as a file.
02

Study summary

Residents living in long-term care (LTC) homes spend up to 75% of their day in sedentary, socially withdrawn situations which increases their risk for depression, dementia, decreased functional status and increased care costs. Physical activity is an accepted intervention to improve the physical health, cognition, and well-being of older adults. Moreover, systematic reviews have found that exergaming (i.e. physical activity gamified with technology) offers physical, cognitive, and social benefits by means of dual-task activities that engage both motor and cognitive abilities. The effect of exergaming for older adults in LTC is less clear, as this population has greater health needs related to physical health conditions, cognitive impairment, and functional dependence. Given the increased global demand for LTC, there is a need to develop and assess innovative exergaming technologies that can support the physical and cognitive health of LTC residents.

MouvMat is an exergaming technology intervention with an interactive digital gaming surface designed for older adults (OA) in LTC settings. Participants can play familiar games, like Simon or Bingo, by stepping on or tapping the surface with an assistive pointing device. Games can be played individually or with multiple players. LED lights on the surface provide an adaptive digital display and embedded pressure sensors respond to players' input. The investigators collaboratively designed a preliminary prototype with OA aged 65 and older in a pilot project.

The overall objective of this proposal is to conduct a pilot RCT of the Mouvmat to evaluate the feasibility, acceptability and efficacy of the exergaming technology to improve the primary outcome of mobility, and the secondary outcomes of cognitive function and social isolation compared to a usual care control group receiving standard recreational programming by recreational therapists.

Read the detailed description

The sample size calculation was completed based on an effect size of 0.65 (power = 0.80; 2-tailed; α= 0.05). Assuming a 5% attrition rate, a total of 56 residents (28 people in a control group and 28 people in the intervention group) will be recruited. A block randomization design using a number generator to conceal the randomization sequence will be used to assign participants' units to the intervention or control groups. Block randomization was conducted to comply with COVID-19 restrictions. The investigators will attempt to recruit equal numbers of men and women with a range of mobility requirements (i.e., ambulate independently, using gait aids such as canes or walkers). In addition, a mix of approximately 5-10 LTC staff and/or residents' family members will be recruited at the end of the trial to conduct semi-structured interviews to understand the acceptability of the technology, design, usability and enjoyment, potential facilitators and barriers to exergame technology.

03

Conditions studied

  • Physical Inactivity
  • Cognitive Decline
  • Aging
  • Social Isolation

Keywords

  • nursing homes
  • long-term care
  • exergaming
  • user-centered design
  • older adult
  • aging
  • depression
  • dementia
04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All residents at the participating long-term care homes are eligible if they are 55 years of age or older
  • Ability to communicate and speak English
  • Able to provide or have a substitute decision maker (SDM) who provides informed consent
  • A family member, friend, or personally-hired caregiver of an older adult residing in one of our participating LTC facilities are eligible to participate if they are 18 years of age or older, can communicate and speak English
  • The LTC resident does not need to be enrolled in or study in order for their family member/friend/caregiver to participate
  • LTC staff are eligible if they can communicate and speak English, are currently working in one of the participating LTC facilities, have at least 6 months experience working with older adults in LTC, providing or supervising physical or recreational activities, or involved with purchasing or directing these activities, and are a member of one of the following professions/positions: physiotherapist, physiotherapy assistant, recreational therapist, or LTC administrator.

Exclusion criteria

Exclusion Criteria:

  • Residents will be ineligible to participate in the study is they cannot communicate or speak English
  • Residents who typically do not participate in recreational activities
  • Residents who have a severe sensory (e.g., deaf, blind) or severe to moderate cognitive impairment AND/OR scores less than 20 on the Mini- Mental Status Examination ()
  • Family Members who cannot communicate or speak English
  • Family Members who cannot interact with the MouvMat due to sensory limitations (i.e., severe visual or auditory impairment)
  • Family Members who cannot provide verbal feedback
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    MouvMat Exergaming

    Older adults in the intervention group will participate in a 6-week, 3 times per week, 45 minutes per session exercise program involving use of the MouvMat. Each resident from the intervention group will engage with the exergame supervised by a qualified and trained RA. Each intervention session will involve groups of 4-5 participants, with participants taking turns. An RA blinded to participants' condition will collect the outcome data.

    Behavioral: MouvMat Exergaming

  • Other
    Standard Recreational Programming

    A control group will meet on a similar schedule as the MouvMat group for standard recreational programming conducted by onsite recreational therapists. The same RA from the experimental group will collect outcome measurements from control group participants.

    Behavioral: Standard Recreational Programming

Interventions

  • BehavioralMouvMat Exergaming

    Sessions engaging with exergaming device.

  • BehavioralStandard Recreational Programming

    Conducted by recreational therapists.

06

What researchers measure

Primary outcomes

  1. Change in mean mobility scores on the Timed-up-and-Go test

    Completion time in seconds when participant sits in a standard armchair and is instructed to stand up and walk to a line 3 m away at their normal pace, turn around and sit back down in the chair.

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  2. Change in mean mobility scores on the Timed-up-and-Go test

    Completion time in seconds when participant sits in a standard armchair and is instructed to stand up and walk to a line 3 m away at their normal pace, turn around and sit back down in the chair.

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  3. Change in mean mobility scores on the 2-Minute Walk Test

    Distance walked in meters when a participant is instructed to walk at the fastest speed that they can for 2 minutes.

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  4. Change in mean mobility scores on the 2-Minute Walk Test

    Distance walked in meters when a participant is instructed to walk at the fastest speed that they can for 2 minutes.

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  5. Adverse events (e.g. injury) related to exergame use

    Number of adverse events related to use of the exergame in the intervention group

    Time frame: Over the course of the intervention (baseline to 6 weeks)

  6. Feasibility related to adherence rate

    Mean percentage of sessions attended in the intervention group (i.e., number of sessions attended / total scheduled sessions)

    Time frame: Over the course of the intervention (baseline to 6 weeks)

Secondary outcomes

  1. Change in mean working memory scores on digit span

    Total scores for the WAIS-III forward and backward digit span, in which participants are asked to repeat a series of digits that are read by an experimenter in the same order (forward) or reverse order (backward).

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  2. Change in mean working memory scores on digit span

    Total scores for the WAIS-III forward and backward digit span, in which participants are asked to repeat a series of digits that are read by an experimenter in the same order (forward) or reverse order (backward).

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  3. Change in mean basic attention/psychomotor speed on the Trail Making Test A

    Time to completion in seconds on a task requiring connecting numbered dots on a page in order as quickly as possible.

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  4. Change in mean basic attention/psychomotor speed on the Trail Making Test A

    Time to completion in seconds on a task requiring connecting numbered dots on a page in order as quickly as possible.

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  5. Change in mean alternating attention scores on the Trail Making Test B

    Time to completion in seconds on a task requiring switching between connecting numbers and letters in dots on a page as quickly as possible.

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  6. Change in mean alternating attention scores on the Trail Making Test B

    Time to completion in seconds on a task requiring switching between connecting numbers and letters in dots on a page as quickly as possible.

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  7. Change in errors made on an alternating sequences test

    Number of errors made on a task requiring alternating between drawing two designs. This test is sensitive to cognitive problems with executive functions including inhibition and perseveration.

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  8. Change in errors made on an alternating sequences test

    Number of errors made on a task requiring alternating between drawing two designs. This test is sensitive to cognitive problems with executive functions including inhibition and perseveration.

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  9. Change in mean verbal fluency scores

    Number of words generated in one minute given a letter cue

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  10. Change in mean verbal fluency scores

    Number of words generated in one minute given a letter cue

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  11. Change in mean scores for social isolation assessed by UCLA Loneliness Scale 3

    Total score on a 20-item questionnaire that assesses how often a person feels lonely and isolated from others.

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  12. Change in mean scores for social isolation assessed by UCLA Loneliness Scale 3

    Total score on a 20-item questionnaire that assesses how often a person feels lonely and isolated from others.

    Time frame: Baseline and following the completion of the intervention (6 weeks)

  13. Change in mean scores on the Cornell Scale for Depression in Dementia

    Total scores on a measure based on interviews on 19 items related to depression.

    Time frame: Baseline and mid-point of the intervention (3 weeks)

  14. Change in mean scores on the Cornell Scale for Depression in Dementia

    Total scores on a measure based on interviews on 19 items related to depression.

    Time frame: Baseline and following the completion of the intervention (6 weeks)

Other outcomes

  1. Acceptability on a version of the modified Treatment Evaluation Inventory (m-TEI) adapted for exergame use

    Mean total score from intervention group participants and family members/staff

    Time frame: Following the completion of the intervention (6 weeks)

  2. Semi-structured interviews to evaluate the acceptability of the technology, design, usability and enjoyment, potential facilitators and barriers

    A semi-structured interview will be completed with residents in the intervention group, as well as stakeholders including family members and staff, with questions designed to understand the acceptability of the technology, design, usability and enjoyment, potential facilitators and barriers to exergame technology. The post-intervention interviews will be analyzed using thematic analysis.

    Time frame: Following the completion of the intervention (6 weeks)

07

Study locations

1 of 2 sites recruiting
  • Chester Village
    Toronto, Canada
    Completed

    Not enrolling at this site.

  • Kensington Gardens
    Toronto, Canada
    Recruiting
    • Charlene · Contact
08

References and documents

Publications

  • Ikezoe T, Asakawa Y, Shima H, Kishibuchi K, Ichihashi N. Daytime physical activity patterns and physical fitness in institutionalized elderly women: an exploratory study. Arch Gerontol Geriatr. 2013 Sep-Oct;57(2):221-5. doi: 10.1016/j.archger.2013.04.004. Epub 2013 May 9. PubMed 23664785 ↗
  • Chu CH, Puts M, Brooks D, Parry M, McGilton KS. A Feasibility Study of a Multifaceted Walking Intervention to Maintain the Functional Mobility, Activities of Daily Living, and Quality of Life of Nursing Home Residents With Dementia. Rehabil Nurs. 2020 Jul/Aug;45(4):204-217. doi: 10.1097/rnj.0000000000000186. PubMed 30325875 ↗
  • Shankar A, McMunn A, Demakakos P, Hamer M, Steptoe A. Social isolation and loneliness: Prospective associations with functional status in older adults. Health Psychol. 2017 Feb;36(2):179-187. doi: 10.1037/hea0000437. Epub 2016 Oct 27. PubMed 27786518 ↗
  • de Souto Barreto P, Morley JE, Chodzko-Zajko W, H Pitkala K, Weening-Djiksterhuis E, Rodriguez-Manas L, Barbagallo M, Rosendahl E, Sinclair A, Landi F, Izquierdo M, Vellas B, Rolland Y; International Association of Gerontology and Geriatrics - Global Aging Research Network (IAGG-GARN) and the IAGG European Region Clinical Section. Recommendations on Physical Activity and Exercise for Older Adults Living in Long-Term Care Facilities: A Taskforce Report. J Am Med Dir Assoc. 2016 May 1;17(5):381-92. doi: 10.1016/j.jamda.2016.01.021. Epub 2016 Mar 21. PubMed 27012368 ↗
  • Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, Lloyd-Sherlock P, Epping-Jordan JE, Peeters GMEEG, Mahanani WR, Thiyagarajan JA, Chatterji S. The World report on ageing and health: a policy framework for healthy ageing. Lancet. 2016 May 21;387(10033):2145-2154. doi: 10.1016/S0140-6736(15)00516-4. Epub 2015 Oct 29. PubMed 26520231 ↗
  • Chu CH, Biss RK, Cooper L, Quan AML, Matulis H. Exergaming Platform for Older Adults Residing in Long-Term Care Homes: User-Centered Design, Development, and Usability Study. JMIR Serious Games. 2021 Mar 9;9(1):e22370. doi: 10.2196/22370. PubMed 33687337 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2022 (actual). Primary completion is estimated for Jan 2025, 27 months after the start.

Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 27 months is above that.

Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2021
First posted
Nov 23, 2021
StartActual
Oct 1, 2022
Primary completionEst.
Jan 2025
CompletionEst.
Jan 2025
Last update
Jun 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05130203
Collaborators
Social Sciences and Humanities Research Council of Canada
Responsible party
Charlene Chu (Assistant Professor, University of Toronto) — Principal investigator
First posted
Nov 23, 2021
Start date
Oct 1, 2022
Primary completion
Jan 2025 (estimated)
Completion
Jan 2025 (estimated)
Last update
Jun 13, 2024

Study contacts

Charlene Chu, PhD
Contact
charlene.chu@utoronto.ca
416-946-0217
Shefali Ram
Contact
s.ram@utoronto.ca
416-946-8304
Charlene Chu, PhD
principal investigator · University of Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion